The PrEDiCaTE study – the first in Kazakhstan on chemotherapy-linked cardiotoxicity in breast cancer patients
Dr Saule Balmagambetova and Dr Zhenisgul Tlegenova discuss the PrEDiCaTE study, which aims to develop a program for early diagnosis and treatment of the heart complications of breast cancer chemotherapy, and was registered at the ISRCTN registry.